Literature DB >> 3407777

A simple method for chronic cannulation of the portal vein in intact unrestrained rats.

A Braillon1, M J Brody.   

Abstract

A simple new method is described for chronic cannulation of the portal vein in rats. A Silastic catheter (0.64 mm OD) with an internal metallic leader is directly inserted in the junction of the two small ileal veins. The catheter is advanced into the mesenteric vein to the portal vein. Then the leader is removed and the catheter tunneled out the back of the neck. This method allows for the measurement of portal vein pressure, direct injection of substances in the portal vein, or blood samples for at least 1 wk in intact unrestrained rats. Validation included the presence of elevated portal vein pressure in portal hypertensive rats compared with normal rats and the absence of clot development in the portal vein. This method should help provide a better understanding of hepatic physiology and pharmacology in normal and disease states.

Entities:  

Mesh:

Year:  1988        PMID: 3407777     DOI: 10.1152/ajpgi.1988.255.2.G191

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.

Authors:  Frédéric Moal; Nary Veal; Eric Vuillemin; Eric Barrière; Jianhua Wang; Lionel Fizanne; Frédéric Oberti; Olivier Douay; Yves Gallois; Dominique Bonnefont-Rousselot; Marie Christine Rousselet; Paul Calès
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

2.  Adrenergic, purinergic, and endothelial mediators and modulators of norepinephrine-induced mesenteric autoregulatory escape.

Authors:  G Remak; O D Hottenstein; E D Jacobson
Journal:  Dig Dis Sci       Date:  1994-08       Impact factor: 3.199

3.  Blood Sampling From Rat Ileal Mesenteric Vein Revealed a Major Role of Dietary Protein in Meal-Induced GLP-1 Response.

Authors:  Tohru Hira; Madoka Sekishita; Hiroshi Hara
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-02       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.